Blockchain Registration Transaction Record

NeuroOne Medical Technologies Set to Join Russell Microcap Index

NeuroOne Medical Technologies (NMTC) joins Russell Microcap Index, boosting visibility for its FDA-cleared electrode and ablation technologies for neurological disorders.

This news matters because inclusion in the Russell Microcap® Index can significantly increase NeuroOne's visibility among institutional investors, potentially leading to a broader shareholder base and more capital for advancing its innovative neurological treatments. For patients and healthcare providers, this could accelerate the development and adoption of NeuroOne's minimally invasive electrode and ablation technologies, which aim to reduce hospitalizations, lower costs, and improve outcomes for neurological disorders. The index reconstitution also reflects the growing importance of medical technology companies in the investment landscape.